Published in Acta Oncol on January 01, 2002
An update on management of lung cancer--Acta Oncologica Lecture-Västerås 21 March 2002. Acta Oncol (2002) 1.39
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med (2014) 9.09
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. J Clin Oncol (2012) 2.45
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J (2004) 2.20
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther (2006) 1.46
Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol (2004) 1.46
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? Eur J Cancer (2007) 1.44
Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol (2002) 1.34
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol (2003) 1.31
Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst (2008) 1.30
Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer (2003) 1.21
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet (2007) 1.19
LRIG1 protein in human cells and tissues. Cell Tissue Res (2003) 1.18
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics (2004) 1.17
Dysregulated secretoglobin expression in human lung cancers. Lung Cancer (2003) 1.17
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol (2010) 1.17
Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet (2011) 1.12
Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (2006) 1.10
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.09
LRIG1 expression in colorectal cancer. Acta Oncol (2007) 1.08
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol (2003) 1.05
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology (2009) 1.05
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys (2005) 1.04
Characterization and tissue-specific expression of human LRIG2. Gene (2004) 1.04
The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev (2008) 1.02
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer (2011) 1.01
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res (2009) 1.01
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer (2009) 1.00
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncol (2010) 0.99
Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol (2006) 0.97
Increased copy number at 3p14 in breast cancer. Breast Cancer Res (2005) 0.97
MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer (2009) 0.97
Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncol (2011) 0.97
Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma. Int J Oncol (2012) 0.96
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev (2007) 0.95
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer (2003) 0.95
Pharmacological modulation of lung cancer cells for potassium ion depletion. Anticancer Res (2005) 0.92
PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Breast Cancer Res Treat (2007) 0.92
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat (2011) 0.92
Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp Cell Res (2010) 0.92
Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. Neurosurgery (2003) 0.91
Lrig2-deficient mice are protected against PDGFB-induced glioma. PLoS One (2013) 0.91
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol (2005) 0.89
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. Prostate (2007) 0.89
Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors. Anticancer Res (2012) 0.89
Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia. Eur J Haematol (2008) 0.89
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. J Neurooncol (2008) 0.89
p53 Genotypes and risk of glioma and meningioma. Cancer Epidemiol Biomarkers Prev (2005) 0.89
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. J Neurooncol (2008) 0.89
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma. BMC Res Notes (2012) 0.88
Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol (2003) 0.88
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. Int J Cancer (2012) 0.88
ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family. Acta Oncol (2004) 0.88
Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol (2010) 0.87
A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs (2008) 0.87
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). J Neurooncol (2006) 0.87
LRIG and cancer prognosis. Acta Oncol (2014) 0.87
[Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. Lakartidningen (2007) 0.86
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition. Clin Cancer Res (2006) 0.86
Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol (2012) 0.86
EGFR gene variants are associated with specific somatic aberrations in glioma. PLoS One (2012) 0.86
Brain tumors in Sweden: data from a population-based registry 1999-2012. Acta Oncol (2014) 0.86
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome. Breast Cancer Res Treat (2011) 0.85
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer. Breast Cancer Res Treat (2011) 0.85
Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas. Acta Neuropathol (2005) 0.84
Severely diseased lung cancer patients narrate the importance of being included in a helping relationship. Lung Cancer (2005) 0.84
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol (2012) 0.84
A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma. Anticancer Res (2012) 0.84
DNA-repair gene variants are associated with glioblastoma survival. Acta Oncol (2011) 0.83
Redistribution of LRIG proteins in psoriasis. J Invest Dermatol (2007) 0.83
Acquisition of cisplatin-resistance in malignant mesothelioma cells abrogates Na+,K+,2Cl(-)-cotransport activity and cisplatin-induced early membrane blebbing. Cell Physiol Biochem (2008) 0.83
Spatial expression of VEGF-A in human glioma. J Neurooncol (2002) 0.83
Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation. Anticancer Res (2008) 0.82
Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. Eur J Cancer (2011) 0.82
Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer. Breast Cancer Res (2009) 0.81
CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett (2008) 0.80
LRIG1 is a prognostic biomarker in non-small cell lung cancer. Acta Oncol (2015) 0.80
Clinical value of using serological cytokeratins as therapeutic markers in thoracic malignancies. Anticancer Res (2007) 0.80
[Free of charge mammography gets more people to the examination. Study in Stockholm County shows good efficacy in socioeconomically disadvantaged areas]. Lakartidningen (2014) 0.80
Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate. J Cancer Res Clin Oncol (2002) 0.79
Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath technique. Acta Oncol (2003) 0.79
Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma: a new era in the treatment of malignant brain tumours? Acta Oncol (2009) 0.79
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival. Breast Cancer Res Treat (2011) 0.78
Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas. J Neurooncol (2011) 0.78
Induction of apoptosis in resistant glioma cells by synthetic caspase-activation. J Neurooncol (2004) 0.78
Reproducibility and geometric accuracy of the Fixster system during hypofractionated stereotactic radiotherapy. Radiat Oncol (2008) 0.78
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer. Med Oncol (2012) 0.78
A specialist nurse-function in neurooncology: a qualitative study of possibilities, limitations, and pitfalls. Palliat Support Care (2005) 0.77
The creation of hope in patients with lung cancer. Acta Oncol (2014) 0.77